Physiologic approach for coronary intervention

William F Fearon1

  • 1Division of Cardiovascular Medicine, Stanford University Medical Center, Stanford, CA 94305, USA. wfearon@stanford.edu

Insights

Fractional flow reserve (FFR) accurately identifies coronary artery disease causing symptoms and future cardiac events. FFR-guided treatment improves outcomes for significant lesions, while non-significant ones can be managed medically.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Assessing coronary artery disease invasively requires identifying symptom-causing and prognostically significant lesions.
  • Myocardial ischemia is the key indicator of lesion significance for symptoms and future cardiac events.

Purpose of the Study:

  • To highlight the role of Fractional Flow Reserve (FFR) as the reference standard in identifying ischemia-producing coronary artery lesions.
  • To emphasize the benefits of FFR-guided percutaneous coronary intervention and medical management.

Main Methods:

  • Utilizing a coronary pressure wire to measure FFR in the catheterization laboratory.
  • Assessing lesion-specific ischemia with high spatial resolution.

Main Results:

  • FFR is the gold standard for identifying ischemia-producing lesions, offering vessel-specific and lesion-specific accuracy.
  • FFR-guided percutaneous coronary intervention improves patient outcomes and resource utilization.
  • Non-hemodynamically significant lesions managed medically show a low rate of subsequent cardiac events.

Conclusions:

  • FFR measurement is crucial for accurate diagnosis and guiding treatment in coronary artery disease.
  • FFR-guided revascularization improves outcomes compared to non-guided approaches.
  • Medical management is a safe and effective strategy for non-significant coronary lesions.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...